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The objective of this study was to identify anti-inflammatory peptides from simulated
gastrointestinal digest (pepsinepancreatin hydrolysate) of velvet antler protein. The hy-
drolysate was purified using ultrafiltration and consecutive chromatographic methods. The
anti-inflammatory activity of the purified fraction was evaluated by the inhibition of NO
production in lipopolysaccharide-induced RAW 264.7 macrophages. Four anti-
inflammatory peptides, VH (ValeHis), LAN (LeueAlaeAsn), AL (AlaeLeu), and IA (Ile
eAla), were identified by liquid chromatography/tandemmass spectrometry. Each of these
peptides demonstrated a U-shaped doseeeffect relationship. VH, LAN, AL and IA showed
the strongest anti-inflammatory activities at 200 mg/mL, that is, 15.5%, 13.0%, 16.0% and
11.2% inhibition of lipopolysaccharide-induced NO production, respectively. Additionally,
the enhanced NO inhibitory activity was observed for the peptides mixture, indicating the
possible synergistic effects. These results suggested that the peptides derived from velvet
antler protein could potentially be used as a promising ingredient in functional foods or
nutraceuticals against inflammatory diseases.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Recently, it has been recognized that proteins provide a source
of bioactive peptides with different health-promotingand Technology Resea
istrict, Beijing 100048, Ch
L. Zhao).
inistration, Taiwan. Publis
/licenses/by-nc-nd/4.0/).properties. These peptides can be produced from proteins
during gastrointestinal digestion, fermentation or enzymatic
hydrolysis. Several studies have shown that anti-
inflammatory peptides can be obtained from protein hydro-
lysates [1e5]. Ahn et al isolated an anti-inflammatoryrch Center of Food Additives, Beijing Technology and Business
ina.
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protein, which inhibited the production of NO, prostaglandin
E2, tumor necrosis factor a, interleukin (IL)-6, and IL-1b, as
well as the expression of inducible NO synthase (iNOS) and
cyclooxygenase-2 in lipopolysaccharides (LPS)-induced RAW
264.7 macrophages [1]. Oseguera-Toledo et al demonstrated
that peptides from common bean inhibited inflammation
through modulation of nuclear factor-kB pathways and
blocking translocation of p65 subunit in LPS-stimulated
RAW264.7 macrophages [2]. Peptides (LDAVNR and MMLDF)
from enzymatic hydrolysate of the edible microalgae Spirulina
maxima inhibit histamine release from mast cells and IL-8
generation from endothelial cells [3]. In addition, peptides
from enzymatic hydrolysates of soy products [4] and Ruditapes
philippinarum [5] also possess anti-inflammatory activities by
inhibiting NO production in LPS-induced RAW 264.7
macrophages.
Velvet antler refers to the whole cartilaginous antler in a
precalcified stage. It has been used for thousands of years in
traditional Chinese medicine and functional food as an aid to
help people maintain overall wellness. In recent decades,
velvet antler has been reported to have pharmacological ac-
tivity, such as immunomodulatory [6,7], anti-inflammatory
[8,9], and wound-healing effects [10]. Velvet antler is a good
source of protein, which may account for 60% (w/w) of dry
matter [11]. However, velvet antler protein (VAP) has only
received limited attention as a potential bioactive resource.
Exploring bioactivities of protein from velvet antler is of sig-
nificance to expand its applications in functional foods and
nutraceuticals. Although an anti-inflammatory peptide with
68 amino acid residues (7.2 kDa) has been isolated from the
antlers of Cervus nippon Temminck [9], there exists, to our
knowledge, no further information about anti-inflammatory
peptides derived from protein hydrolysates of velvet antler
and the primary structure.
To evaluate the possibility of releasing bioactive peptides
after consumption of food proteins, simulated gastrointes-
tinal digestion has been used to mimic human digestion of
proteins. The combination of pepsinepancreatin has been
used to simulate the gastrointestinal degradation of proteins
in humans [7]. The objective of this study was to determine
the effect of simulated gastrointestinal digest fromVAP on the
response of RAW 264.7 macrophages to inflammatory LPS
in vitro. Peptides with molecular weight (MW) < 3 kDa were
fractionated by gradient ethanol elution from a macroporous
adsorption resin, and then separated on Sephadex G-15 and
reverse-phase high performance liquid chromatography (RP-
HPLC). Identification of the anti-inflammatory peptides was
accomplished by liquid chromatography tandem mass spec-
trometry (LC-MS/MS).2. Materials and methods
2.1. Materials
Velvet antlers (Cervus elaphus Linnaeus) were obtained from
male red deer that were bred at the Daxing'anMountain range
(Heilongjiang, China). Samples were freeze-dried, homoge-
nized, and stored at 4C. Pepsin (EC 3.4.23.1,  2500 U/mg),pancreatin (8 USP specifications), LPS, protease inhibitors
cocktail, Sephadex G-15, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), and L-Tyr were pur-
chased from SigmaeAldrich (Shanghai, China). Murine
macrophage cell line RAW 264.7 (ATCC TIB-71) was purchased
from Cell Culture Center of Institute of Basic Medical Sciences
Chinese Academy of Medical Sciences (Beijing, China). Dul-
becco's modified Eagle's medium and fetal bovine serumwere
purchased from Gibco BRL (Grand Island, NY, USA). Pen-
icillinestreptomycin and NO Assay kit were purchased from
Beyotime Biotechnology (Shanghai, China). HPLC-grade
acetonitrile was purchased from Mallinckrodt Baker (Phil-
lipsburg, NJ, USA). All other chemicals were of analytical grade
unless otherwise mentioned.
2.2. Preparation of VAP
VAP was prepared according to Gao et al [12] with some
modifications. Ten grams of velvet antler powder was incu-
bated with 80 mL extract solution (100mM Tris þ 6M
guanidineeHCl þ 20mM EDTA-2Na) at 4C for 36 hours, fol-
lowed by addition of 1% (v/v) protease inhibitors cocktail. After
centrifugation at 5000 g for 30 minutes, the supernatant was
brought to 70% saturation with solid ammonium sulfate. The
protein pellet was recovered by centrifugation (5000 g for
30 minutes at 4C), suspended in 20mM TriseHCl buffer (pH
7.4) and dialyzed for 24 hours at 4C against the same buffer.
The dialysate was then lyophilized and the resulting protein
extract was used for further investigations. The yield of VAP
was 34.2% (w/w, in terms of dry weight of velvet antler).
2.3. Amino acid composition
The amino acid composition of VAP was determined using an
L-8900 amino acid autoanalyzer (Hitachi, Tokyo, Japan) with
an ion exchange column (4.6 mm  60 mm). The sample was
hydrolyzed in 6M HCl under vacuum at 110C for 24 hours.
Amino acids were detected and quantified at 570 nm for pri-
mary amines or at 440 nm for proline after a post-column
reaction with ninhydrin at 135C. Tryptophan content was
determined after alkaline hydrolysis. The contents of indi-
vidual amino acids were expressed as g/100 g of VAP.
2.4. Preparation of simulated gastrointestinal digests of
VAP
In vitro simulated gastrointestinal digestion of VAPwas carried
out as reported previously [7] with slight modifications. VAP
solution (5% w/v, in distilled water) was adjusted to pH 2.0
with 10M HCl, and pepsin (enzyme/substrate ratio of 1:100, w/
w) was added. The solution was incubated at 37C for 2 hours
under constant stirring. After pepsin hydrolysis, the pH of the
solution was adjusted to 6.8 with 10M NaOH, and pancreatin
(enzyme/substrate ratio of 1:50, w/w) was added. The solution
was incubated at 37C for a further 4 hours under constant
stirring. During the enzymatic hydrolysis, the pH of the solu-
tion was maintained constant by means of pH-stat technique
using 1M HCl or 1M NaOH. After hydrolysis, enzymes were
inactivated by heating in boiling water for 10 minutes. The
hydrolysate was centrifuged at 10,000 g and 4C for
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ultrafiltration cell (Model 8050; Millipore, Bedford, MA, USA)
equipped with 3 kDa MW cut-off membrane to obtain the
peptides fraction (SGD-VAP) with MW < 3 kDa. The resultant
SGD-VAP solution was lyophilized and stored at 20C for
further use.
2.5. Determination of anti-inflammatory activity
2.5.1. Cell culture and cell viability
Murine macrophage cell line RAW 264.7 was cultured in Dul-
becco's modified Eagle's medium supplemented with 1%
penicillinestreptomycin and 10% fetal bovine serumat 37C in
a humidified atmosphere containing 5% CO2.
Cell viability was estimated by the MTT assay as described
previously [13]. Cells (3  104/well) were seeded in 96-well
plates and treated with various concentrations of samples in
the absence or presence of LPS (10 mg/mL). After incubation for
24 hours, the growth medium was replaced with 100 mL fresh
growth medium. A 20-mL aliquot of MTT solution (5 mg/mL)
was added to each well and incubated for a further 4 hours at
37C. The purple formazan was diluted with 150 mL dimethyl
sulfoxide. The absorbance was measured at 490 nm using a
microplate reader (Spectra Max i3; Molecular Devices, Sun-
nyvale, CA, USA). The percentage of viable cellswas calculated
with respect to the cells treated with phosphate-buffered
saline.
2.5.2. NO measurement in supernatant of RAW 264.7
macrophages
One hundred microliters of RAW 264.7 macrophages (3  105/
mL) were seeded in 96-well plates and incubated with
different concentrations of samples in the absence or pres-
ence of LPS (10 mg/mL). The plates were incubated at 37C in a
humidified incubator with 5% CO2 for 24 hours. After incu-
bation, the supernatant was collected for NO production
measurement. NO production was determined using an NO
Assay Kit (Beyotime Institute of Biotechnology, Nantong,
China). Fifty microliters of supernatant wasmixedwith 100 mL
of the Griess reagent (1% sulfanilamide and 0.1% N-1-
naphthyl-ethylenediamine dihydrochloride in 2.5% phos-
phoric acid) in a 96-well plate. After incubation at room tem-
perature for 10 minutes, absorbance at 550 nm was
determined in a microplate reader. Nitrite concentration was
determined by using NaNO2 as a standard.
2.6. Purification of anti-inflammatory peptides from
SGD-VAP
Ten milliliters of SGD-VAP (30 mg/mL) was loaded onto a
DA201-C (Suqing Chemistry Co., Jiangyin, China) column
(26 mm  400 mm), which was previously equilibrated with
distilled water. Adsorbed peptides were eluted by gradient
ethanol elution at a flow rate of 3 mL/min. The eluent was
monitored by absorbance at 220 nm. Each of the fractions was
pooled, concentrated by rotary evaporation (40C), and freeze
dried. Themost potent anti-inflammatory fractionwas loaded
onto a Sephadex G-15 gel filtration column (16 mm  700 mm)
equilibrated with distilled water. Samples were eluted with
distilled water at a flow rate of 1.5 mL/min. The eluent wasmonitored by absorbance at 220 nm. Fractions were pooled
and freeze dried for an anti-inflammatory assay. The fraction
showing the strongest anti-inflammatory activity was further
purified using preparative RP-HPLC on an Eclipse XDB-C18
column (21.2 mm  250 mm, 7 mm). Eluent A was 0.1% (v/v)
trifluoroacetic acid in acetonitrile and Eluent B was 0.1% (v/v)
trifluoroacetic acid in water. The gradient elution condition
was 0e10 minutes, 1% eluent A; 10e60 minutes, 1e45% eluent
A; 60e70 minutes, 45e100% eluent A; 70e85 minutes, 100%
eluent A. The flow rate was 5 mL/min and temperature was
30C. Elution peaks were monitored at 220 nm, and their anti-
inflammatory activities were measured using the method
previously described.
2.7. Identification and quantification of anti-
inflammatory peptides
The MWs and amino acid sequences of purified peptides were
determined using LC-MS/MS. The LC-MS/MS system consisted
of an Agilent 1290 Infinity LC coupled to an Agilent G6500
quadrupole time-of-flight mass spectrometer (Agilent Tech-
nologies, Santa Clara, CA, USA). LC separations were per-
formed on an Agilent Zorbax Eclipse Plus C18 column
(2.1 mm  50 mm, 1.8 mm). Eluent A was 0.1% (v/v) formic acid
in acetonitrile and Eluent Bwas 0.1% (v/v) formic acid inwater.
Gradient elution was carried out according to the following
process: 0e2 minutes, 1% eluent A; 2e12 minutes, 1e50%
eluent A; 12e15 minutes, 50e100% eluent A; 15e20 minutes,
100% eluent A at a flow rate of 0.2mL/min. The temperature of
the column was 30C and the injection volume was 2 mL.
Peptides eluted were analyzed online by MS and selected
peptides were subjected to MS/MS sequencing. Spectra were
recorded over the mass to charge (m/z) range of 50e3000. A
precursor ion scan of the purified fraction was used to identify
the unique peptide mass, which was then fragmented using a
low collision energy (15 eV) induced dissociation to determine
the peptide fragment for de novo sequencing. High-purity N2
was used for drying (300C, 5.0 L/min), and nebulization (15
psig). The voltage of the capillary was 3.5 kV. The peptide
sequencing was performed by manual calculation.
The peptides were synthesized by GL Biochem (Shanghai,
China) using a solid phase peptide synthesis method. The
purity of the synthesized peptide was evaluated to be 95% by
HPLC analysis, and its MWwas determined using Voyager DE-
Pro matrix-assisted laser desorption/ionization mass spec-
trometry (PE Biosystems, Framingham, MA). These synthetic
peptides were used as standards for the quantification of the
peptides in Fraction H3 using the LC-MS method under the
same conditions. Quantification was carried out by integra-
tion of the extracted ion chromatogram peak areas using
external standard calibration.
2.8. Statistical analysis
Each set of experiments was carried out with three replicates.
Data were expressed as means ± standard deviation. The
differences between two groups were assessed using one-way
analysis of variance followed by Duncan's test. A value of
p < 0.05 was considered statistically significant. The correla-
tion was calculated under Pearson correlation coefficient (2-
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 3 7 6e3 8 4 379tailed) in bivariate correlations. Analysis was done with SPSS
version 13.0 (SPSS, Chicago, IL, USA).3. Results and discussion
3.1. Amino acid composition of VAP
The amino acid composition of VAP is summarized in Table 1.
Glu (9.50 g/100 g) was determined to be the most abundant
amino acid in VAP, followed by Gly, Asp, Leu, Pro and Ala. Trp
was the amino acid present in the lowest amount. The amino
acid composition of VAP was similar to that of velvet antler
reported by Sunwoo et al [11]. VAP contained relatively high
contents of hydrophobic amino acids and positively charged
amino acids, which accounted for 39.1% and 18.1% of the total
amino acids, respectively. Hydrophobic amino acids (such as
Leu and Phe) and positively charged amino acids were re-
ported to have a major influence on the anti-inflammatory
activities of peptides [14,15]. In view of this, we speculated
that anti-inflammatory peptidesmay be obtained fromVAP by
protease hydrolysis.Fig. 1 e Effect of SGD-VAP on the cell viability (A) and NO
production (B) in LPS-induced RAW 264.7 macrophages.
SGD-VAP, peptides fraction (molecular weight < 3 kDa)
obtained from simulated gastrointestinal digest of velvet
antler protein by ultrafiltration. *p < 0.05, **p < 0.01 are
significantly different compared with the group treated
with only LPS. LPS ¼ lipopolysaccharide; SGD ¼ simulated
gastrointestinal digest; VAP, velvet antler protein.3.2. NO inhibitory activity of SGD-VAP
Pepsinepancreatin hydrolysis was performed in order to
simulate gastrointestinal digestion of VAP. The ultrafiltration
fraction with MW < 3 kDa (SGD-VAP) accounted for 54.8% (w/
w) of VAP hydrolysates (data not shown), indicating that VAP
was mainly converted into low-MW peptides. Previous study
has reported that low-MW peptides are less susceptible to
proteolytic enzymes and could be easily absorbed by intesti-
nal cells after oral administration [16]. Thus, SGD-VAP
(MW< 3 kDa) fromSGDs of VAPwas selected for further study.
The cytotoxicity of SGD-VAP in RAW 264.7 macrophages
was determined using the MTT assay prior to evaluating its
anti-inflammatory activity. As shown in Fig. 1A, SGD-VAP did
not exhibit any cytotoxic effect on RAW 264.7 macrophages atTable 1 e Amino acid compositions of velvet antler
protein.
Amino
acids
Content
(g/100 g)
Amino
acids
Content
(g/100 g)
Thr 3.45 ± 0.20 Ser 3.81 ± 0.21
Val 3.91 ± 0.17 Glu 9.50 ± 0.29
Met 1.02 ± 0.06 Gly 8.29 ± 0.27
Ile 1.71 ± 0.18 Ala 5.87 ± 0.10
Leu 6.78 ± 0.22 Cys 1.41 ± 0.09
Phe 3.55 ± 0.15 Tyr 2.28 ± 0.08
Lys 5.73 ± 0.18 Arg 5.50 ± 0.26
Trp 0.65 ± 0.03 Pro 6.31 ± 0.25
Asp 7.27 ± 0.28 His 3.25 ± 0.15
HAAsa 31.34 ± 0.06 PCAAsc 14.49 ± 0.56
AAAsb 6.48 ± 0.10 Total 80.20 ± 0.76
Values are reported as the means ± standard deviation (n ¼ 3).
a Hydrophobic amino acids (Ala, Val, Met, Ile, Leu, Phe, Pro and
Tyr).
b Aromatic amino acids (Phe, Trp and Tyr).
c Positively charged amino acids (Arg, Lys and His).the tested concentrations (100e2000 mg/mL). SGD-VAP signif-
icantly (p < 0.01) enhanced the viability of LPS-induced mac-
rophages at 200 mg/mL and 500 mg/mL, showing 24.3% and
31.7% increase in cell viability, respectively. Thus, the
nontoxic concentrations (100e2000 mg/mL) of SGD-VAP were
used to evaluate its NO inhibitory activities in LPS-induced
RAW 264.7 macrophages.
LPS, a component of the Gram-negative cell wall, was used
to activate macrophages. Overproduction of NO can be
induced quantitatively in activated macrophages, which is
related to inflammatory responses [7]. Therefore, inhibition of
NO production in LPS-induced macrophages is one of the
possible ways to screen anti-inflammatory components. To
investigate the inhibitory effect of SGD-VAP on NO produc-
tion, the accumulation of nitrite in the culture media was
measured. As shown in Fig. 1B, treating RAW 264.7 macro-
phageswith LPS resulted in 13.6-fold increased NO production
compared to that in the blank group. SGD-VAP significantly
inhibited LPS-induced NO production from RAW 264.7 mac-
rophages in a dose-dependent manner (r ¼ 0.985, p < 0.01).
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at 200 mg/mL (15.5% inhibition). At 2 mg/mL, SGD-VAP inhibi-
ted NO production by 73.7%. It was suggested that VAP con-
tained some anti-inflammatory peptide fragments, which can
be released during simulated gastrointestinal digestion. Puri-
fication and identification of these bioactive peptides from
SGD-VAP could provide insights into the development of new
anti-inflammatory products.Fig. 2 e Purification of anti-inflammatory peptides from SGD-V
macroporous adsorption resin. (C) Gel filtration chromatogram o
high-performance liquid chromatography of Fraction G2 from (C
SGD-VAP, peptides fraction (molecular weight < 3 kDa) obtaine
protein by ultrafiltration. Means with different superscripts are
gastrointestinal digest; VAP, velvet antler protein.3.3. Purification of anti-inflammatory peptide
Sequential chromatography was used to purify anti-
inflammatory peptides from SGD-VAP, including DA201-C
macroporous adsorption resin, Sephadex G-15 gel filtration
chromatography, and RP-HPLC. Fig. 2 illustrates the column
chromatographic profiles of SGD-VAP and the anti-
inflammatory activities of the fractions.
DA201-C macroporous adsorption resin is a nonpolar resin
that adsorbs hydrophobic peptides. It has been used to sepa-
rate peptides in protein hydrolysates by hydrophobicity usingAP. (A) Chromatogram of SGD-VAP separated by DA201-C
n Sephadex G-15 of Fraction F2 from (A). (E) Reverse-phase
). (B, D, F) NO inhibitory activity of the separated fractions.
d from simulated gastrointestinal digest of velvet antler
significantly different (p < 0.05). SGD ¼ simulated
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 3 7 6e3 8 4 381an ethanol gradient elution [17]. SGD-VAP was initially sepa-
rated into three fractions (F1eF3) on a DA201-C macroporous
adsorption resin column by gradient ethanol elution (Fig. 2A).
As shown in Fig. 2B, fraction F2 possessed the strongest NO
inhibitory activity among the three fractions. At 500 mg/mL,
fraction F2 inhibited LPS-induced NO production from RAW
264.7 macrophages by 26.4%. Thus, fraction F2 was subjected
to Sephadex G-15 gel filtration column chromatography, and
the active peaks were eluted using distilled water. The pep-
tides in fraction F2 were further separated into four fractions
(G1eG4) (Fig. 2C). Fraction G2 (500 mg/mL) inhibited LPS-
induced NO production from RAW 264.7 macrophages by
42.2%, which was the strongest among the four fractions
(Fig. 2D). Fraction G2 was further purified by RP-HPLC on a C18
column and separated into 10 additional fractions (Fig. 2E).
Fractions eluted with higher concentrations of acetonitrile
probably contained more hydrophobic compounds. Among
these 10 fractions, H3 showed the strongest NO inhibitory
activity. Fraction H3 (500 mg/mL) inhibited LPS-induced NO
production from RAW 264.7 macrophages by 51.6%, which
was about 22.3% higher than that of Fraction G2 from Sepha-
dex G-15 separation.
3.4. Peptide identification by LC-MS/MS analysis
Fraction H3 with relatively high NO inhibitory activity as
indicated above, was subject to LC-MS/MS analysis (Fig. 3).
Using LC-MS, Fraction H3 was separated into six main peaks
(Fig. 3A), whichwere then identified as ninemain components
(P1eP9). The MS/MS spectra are shown in Fig. 3Be3J, from
which the amino acid sequences of peptides from Fraction H3
were identified. Various classical types of fragments (a-ion, b-
ion, c-ion, x-ion, y-ion, and z-ion) were detected in the MS/MS
spectra. Each ion has a weight depending on its components,
according to the following criteria: a-ions, molecular mass of
amino acid residue minus 27; b-ions, plus 1; c-ions, plus 18; x-
ions, plus 45; y-ions, plus 19; and z-ions, plus 3 [18]. After the
manual analysis, eight peptides (AHG, AHWK, VH, L/IAN, L/IA,
AY, AL/I and TL/I) and Tyr from Fraction H3 were achieved,
and none of them were more than four amino acid residues.
Leu/Ile peptide isoforms presented nearly identical MS/MS
profiles. In order to verify the amino sequences of P4, P6, P8
and P9, their retention times were compared with the corre-
sponding Leu/Ile peptide isoforms by HPLC analysis. The
retention times of P4 (1.522 minutes), P6 (2.268 minutes), P8
(3.819 minutes) and P9 (4.068 minutes) were comparable to
those of LAN (1.501 minutes), IA (2.302 minutes), AL
(3.825 minutes) and TL (3.986 minutes), respectively (data not
shown). Thus, P4, P6, P8 and P9 were finally identified as LAN,
IA, AL and TL. The content of each peptide in Fraction H3 was
quantified based on calibration curves made from extracted
ion chromatogram peak areas. The content of AHG, AHWK,
VH, Y, LAN, IA, AY, AL and TL was 1.0%, 1.0%, 2.1%, 13.9%,
2.6%, 6.3%, 4.6%, 16.0% and 13.9%, respectively.
Several low-MW peptides were proved to have anti-
inflammatory activities, such as VPY from soybean [19], PAY
from salmon pectoral fin byproduct [1], LDAVNR and MMLDF
from Spirulina maxima [3], and dipeptides LE, MW, MY and
puroGlu-Leu [20,21]. High-MW peptides (e.g., lunasin) were
also found to have potent anti-inflammatory activities [1].Moreover, all of the identified peptides in our study were
submitted for search in the BIOPEP (http://www.uwm.edu.pl/
biochemia/index.php/pl/biopep/) databases, which contain a
list of biologically active and validated peptide sequences, to
find out if any already established bioactive peptide was to be
found. IA and AY have been reported to possess angiotensin-I-
converting enzyme inhibitory activity. VH, IA, AY, AL and TL
have been found to be dipeptidyl peptidase IV inhibitors,
which are known to exert antidiabetic, cardioprotective and
anti-inflammatory activities [22]. Thus, the anti-inflammatory
activities of the eight identified peptides and Tyr fromFraction
H3 in LPS-induced RAW 264.7 macrophages were further
investigated.
3.5. Anti-inflammatory activity of synthesized peptides
Fig. 4 shows the cytotoxicity and anti-inflammatory activities
of the eight synthesized peptides (AHG, AHWK, VH, LAN, IA,
AY, AL and TL), Tyr, and peptides mixture (PepMix). PepMix
was reconstitutedwith these eight peptides and Tyr according
to their content ratio in Fraction H3. Fig. 4A illustrates that
most of the samples showed no cytotoxic effect on RAW 264.7
macrophages at concentrations below 500 mg/mL. Treatment
with AHWK (500 mg/mL), AY (500 mg/mL), and PepMix (100 mg/
mL) led to a significant increase in cell viability. Although
significant reduction in cell viability was observed in the cells
treated with VH, LAN, TL and IA at 500 mg/mL, the viability
remained > 88.0%. Thus, all samples were tested for their NO
inhibitory activities at 50e500 mg/mL.
As shown in Fig. 4B, the inhibitory activity of AL against
LPS-induced NO production in RAW 264.7 macrophages
became significant at 100 mg/mL,while the inhibitory activities
of VH, LAN, Y and IA became significant at 200 mg/mL. VH,
LAN, Y, AL and IA showed the strongest NO inhibitory activ-
ities at 200 mg/mL, resulting in 15.5%, 13.0%, 12.1%, 16.0% and
11.2% inhibition of LPS-induced NO production, respectively.
When the concentration increased to 500 mg/mL, VH, LAN, AL
and IA showed no significant NO inhibitory activities. The
doseeeffect relationship of VH, LAN, Y, AL and IA followed a
U-shaped curve, with inhibition most significant in the mid-
range of tested concentrations and less inhibition at higher or
lower concentrations. Similarly, marine oligopeptide prepa-
ration [23] and SGD from aqueous extract of velvet antler [7]
have also been found to show bidirectional regulatory ef-
fects. LPS-induced RAW 264.7 macrophages incubated with
PepMix (50e500 mg/mL) showed a dose-dependent inhibitory
activity (r ¼ 0.957, p < 0.05) against the NO production by
macrophages. At 500 mg/mL, PepMix inhibited LPS-induced NO
production in RAW 264.7 macrophages by 33.2% (p < 0.01).
PepMix showed stronger NO inhibitory activity than any in-
dividual peptides at the same concentrations. The results
suggested that the peptides in PepMix might demonstrate
synergistic effects on NO inhibitory activity. Peptides have
been reported to exert synergistic effect in many studies. Yan
et al reported that RPNYTDA and TRTGDPFF showed syner-
gistic antioxidant activity compared to each of them used
alone [24]. Girgih et al and Raghavan and Kristinsson found
that peptides acted synergistically to be more active when
present together in the protein hydrolysate [25,26]. Fraction-
ation of the peptides resulted in loss of this synergistic effect.
Fig. 3 e Identification of anti-inflammatory peptides from Fraction H3 by liquid chromatography tandem mass
spectrometry. (A) Total ion current chromatogram of Fraction H3; (B) P1 (m/z 284.0563, RT 0.732min); (C) P2 (m/z 541.1608, RT
0.741 min); (D) P3 (m/z 255.0707, RT 0.855 min); (E) P4 (m/z 317.1793, RT 1.522 min); (F) P5 (m/z 182.0808, RT 1.600 min); (G) P6
(m/z 203.1389, RT 2.268 min); (H) P7 (m/z 253.1112, RT 2.345 min); (I) P8 (m/z 203.1382, RT 3.819 min); (J) P9 (m/z 233.1497, RT
4.068 min). Following sequence interpretation, P1eP9 were identified as AHG, AHWK, VH, L/IAN, Y, L/IA, AY, AL/I and TL/I,
respectively. RT, retention time.
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Fig. 4 e Effects of identified peptides from Fraction H3 and peptides mixture (PepMix) on the cell viability (A) and NO
production (B) in LPS-induced RAW 264.7 macrophages. *p < 0.05, **p < 0.01 are significantly different compared with the
group treated with only LPS. PepMix was reconstituted with 1.0% AHG, 1.0% AHWK, 2.1% VH, 13.9% Y, 2.6% LAN, 6.3% IA,
4.6% AY, 16.0% AL and 13.9% TL according to their content ratio in Fraction H3. LPS ¼ lipopolysaccharide.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 3 7 6e3 8 4 383However, the inhibitory activity of PepMix was still 35.7%
weaker than that of Fraction H3 from RP-HPLC separation. It
was indicated that some other unidentified components in
Fraction H3 might have NO inhibitory activity.
The structureeactivity relationship of bioactive peptides
(especially antioxidant and angiotensin-I-converting enzyme-
inhibitory peptides) has been extensively studied. The activ-
ities of bioactive peptides depend on their structures, such as
amino acid composition, type of amino acid in C and N
termini, hydrophobicity/hydrophilicity, charge distribution,
length of peptide chain, and spatial structure [27]. Jacquot et al
studied the proliferative effects of 11 immunomodulatory
peptides (MW 554.31e1728.97 Da) and found that longer hy-
drophobic peptides bearing 2e3 positive charges have greater
potential to stimulate the proliferation of murine splenocytes
[28]. Vogel et al suggest that the anti-inflammatory and
immunomodulatory properties are more related to a posi-
tively charged region of the peptide, which may act as achemokine [15]. Although some anti-inflammatory peptides
have been prepared and identified, the effects of structural
groups on their anti-inflammatory activities are not well un-
derstood. Further exploring the structureeactivity relation-
ship and revealing the mechanism of anti-inflammatory
peptides will provide an important theoretical basis for the
development of functional foods or nutraceuticals.4. Conclusions
Our study demonstrated that SGD-VAP (MW < 3 kDa) from
pepsinepancreatin hydrolysate (SGD) of VAP has the potential
to limit LPS-induced inflammation in vitro. The anti-
inflammatory peptides were purified from SGD-VAP by
consecutive chromatographic methods. Four anti-
inflammatory peptides VH, LAN, AL and IA were identified
from SGD-VAP using MS/MS. Each of these peptides
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 3 7 6e3 8 4384demonstrated a U-shaped doseeeffect relationship. In addi-
tion, the anti-inflammatory activity of PepMix might be
related to the synergistic effect of different peptides present in
the mixture. To unravel the potential anti-inflammatory ac-
tivity of SGD-VAP, other unidentified active components
should be clarified. More research is needed to confirm the
potential health benefits of SGD-VAP or its isolated peptides
under inflammatory stress in vivo.Conflicts of interest
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